MAPT and Alzheimer disease: This finding is in line with recent work that also showed a very similar degree of association between amyloid PET and tau PET with tau accumulation rates in CU individuals.70 In prodromal AD (ie, Aβ-positive individuals with MCI), baseline tau PET followed by plasma p-tau217 were the predictors most strongly associated with longitudinal tau PET.